Development and validation of an HPLC-MS/MS method to simultaneously quantify alectinib, crizotinib, erlotinib, gefitinib and osimertinib in human plasma samples, using one assay run
Research output: Contribution to journal › Article › Academic › peer-review
1265Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Development and validation of an HPLC-MS/MS method to simultaneously quantify alectinib, crizotinib, erlotinib, gefitinib and osimertinib in human plasma samples, using one assay run'. Together they form a unique fingerprint.
INIS
Keyphrases
Chemistry
Pharmacology, Toxicology and Pharmaceutical Science